Revolutionizing Precision Medicine with the power of AI and Metabolites
Metabolites are small molecules like glucose & cholesterol that are produced during metabolic processes.
Our patented technology can characterize 20x more metabolites than any other platform for each patient.
We then combine metabolomic data with multi-modal datasets to discover the right treatments for the right patients.
Cardiometabolic treatments are currently determined based on limited factors such as BMI, blood glucose, and basic lipid panels.
We analyze 10,000+ lipids and metabolites to precisely predict which patients develop which complications.
Our digital disease models further predict the right treatment for each patient.
By utilizing multi-modal metabolomics data, we identify novel biological insights to discover new targets, prioritize them in development, explore indication expansion, and strategize drug combinations.
We enhance clinical trial design by developing fine-tuned AI models based on proprietary pre-trained foundation models. These models identify patients most likely to respond and facilitate data-driven covariate identification and adjustment.
Our metabolomics data and pre-trained foundation models improve patient genetic stratification. We partner with liquid biopsy companies to increase the accuracy of their ctDNA tests by integrating metabolomics data.
ADDRESS:
ReviveMed Inc
245 First St.,
Cambridge, MA, 02142
Follow us on: